This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Foulks, C. J. Search for Related Content PubMed PubMed Citation Articles by Foulks, C. J. Social Bookmarking                         What's this?

Dietary Management of Patients in Chronic Renal Failure

Scott & White Clinic, Temple, Texas

Correspondence: Correspondence: Charles J. Foulks, MD, Nephrology 4A, 2401 South 31st Street, Temple, TX 76508. Electronic mail may be sent to cjfoulks{at}swmail.sw.org.

A new oral amino acid preparation was given to two groups of patients: group 1, five patients on hemodialysis; and group 2, five patients with chronic renal failure (CRF). In group 1, significant prediet and postdiet changes were: BUN 93 to 37 mg% (p smaller than .01); creatinine 13.0 to 9.7 mg% (p smaller than .001); phosphorus 6.6 to 4.2 mg% (p smaller than .05); uric acid 8.7 to 6.0 mg% (p smaller than .01); CO₂ 16.3 to 21.3 mEq/L (p smaller than .01); hematocrit 18.0 to 20.8% (p smaller than .05). In group 2: BUN 93 to 66 mg% (p smaller than .05); phosphorus 5.6 to 3.8 mg% (p smaller than .05); hematocrit 27.3 to 30.7% (p smaller than .05). Nitrogen balance was positive in all patients. It is concluded that this oral amino acid mixture is well-tolerated and can be utilized in CRF to attain protein anabolism.

Nutrition in Clinical Practice, Vol. 17, No. 4, 252-254 (2002)
DOI: 10.1177/0115426502017004252


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?